Archives
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
We generate six versions for
2020-08-04

We generate six versions for each benchmark, which are: Table 1 shows the comparison results of the time and memory overhead for each version of benchmark. Note that phosphatidylinositol 4-kinase the results of MM and FFT hardened by CFCSS are much lower than the results in the original paper bec
-
Apoptosis is a multi step
2020-08-04

Apoptosis is a multi-step and multi-pathway cell death program, which is controlled by a diverse range of cell signals [8]. A major hallmark of apoptosis is normotonic cell shrinkage called apoptotic volume decrease (AVD) that occurs at an early phase preceding caspase activation, DNA laddering, and
-
In order to verity if the N B
2020-08-04

In order to verity if the N&B method is able to detect any variation in AT1EYFP and ETAEGFP receptors aggregation propensity due to exogenous treatments in living cells, they were treated by the endogenous peptides Ang II and ET-1, as well as the selective receptors antagonist losartan, BQ123 and si
-
Although IGF upregulation was not sufficient to transform MP
2020-08-04

Although IGF-1 upregulation was not sufficient to transform MPC in our model of ESFT, it is likely to be one of several factors directly or indirectly induced by EWS-FLI-1 that are implicated in MPC transformation and tumorigenicity. It is noteworthy that the age associated with the peak incidence o
-
Studies into regulation of p via PTM processes that
2020-08-04

Studies into regulation of p53 via PTM processes that involve phosphorylation, acetylation, ubiquitination, SUMOylation, neddylation, and methylation are being increasingly reported [23], [24]. Phosphorylation and acetylation of p53 stimulate p53-associated transcription factors [25], [26], whereas
-
In general the ongoing development and improvement of membra
2020-08-04

In general, the ongoing development and improvement of membrane protein crystallography allowed resolving several crystal structures of GPCRs (Ghosh, Kumari, Jaiman, & Shukla, 2015). Several dimer interfaces have been found for class A receptors. One of the most frequent dimer interfaces involves sy
-
We also note that P arcticus is predicted to possesses
2020-08-04

We also note that P. arcticus 273–4 is predicted to possesses an incomplete type IV McrBC-like REase, where the C subunit of the canonical BC complex were missing, making the McrB non-functional [54,55]. An evolutionary explanation for this may be that the substrate for a functional McrBC enzyme is
-
Fatty acid oxidation plays a crucial role in
2020-08-03

Fatty Adaptaquin mg β-oxidation plays a crucial role in maintaining body energy homoeostasis mainly during catabolic states. It mainly occurs in mitochondria and involves a cyclical series of reactions that result in the shortening of fatty acids. Fatty acids comprise an efficient source of energy t
-
br Results and discussion br Conclusion br Experimental sect
2020-08-03

Results and discussion Conclusion Experimental section Pharmacological studies Introduction Survival analysis is a set of statistical methods that aim at modeling the relationship between a set of predictor variables and an outcome variable and, in particular, prediction of the time w
-
Introduction Psoriasis is a chronic recurrent and inflammato
2020-08-03

Introduction Psoriasis is a chronic, recurrent and inflammatory skin disease, and it is characterized by erythema, skin hyperplasia, scales, and hyperproliferation of keratinocyte [1]. It is reported that the psoriasis occurrences are about 3% worldwide [2], but the number varies depending on ethni
-
The expression of DDR receptor has regulated by numerous ty
2020-08-03

The expression of DDR2 receptor has regulated by numerous types of factors depending upon the cell type. During the osteogenic differentiation, the transcription factorATF4 combined with CCAAT/enhancer binding site in the DDR2 promoter, which is responsible for induction of DDR2 transcription [24].
-
chpg Yan et al explored Auraptene
2020-07-31

Yan et al. explored Auraptene 33 isolated from Poncirus trifoliate, a traditional Chinese medicinal plant used for treating inflammation-related diseases to evaluate their activity against prostaglandins E2 (PGE2) and cyclooxygenase-2 (COX-2) on lipopolysaccharide (LPS)-stimulated RAW 264.7 chpg by
-
Compound is fold more potent against NEP
2020-07-31

Compound is 25-fold more potent against NEP than Candoxatrilat , and significantly more selective over ACE than or . Interactions within the S2′ lipophilic pocket are well optimised for NEP. The i.v. pharmacokinetics of compound compare favourably with those of candoxatrilat. Compound has an i.v
-
Although there is some discrepancy in the
2020-07-31

Although there is some discrepancy in the literature regarding the fate of specific CYP450s in vitro, the general consensus remains that the expression of some melk pathway (e.g., CYP3A4, 2C9 and 2D6) recovers to a certain degree after 48–72 h, whereas that of others (e.g., CYP1A2 and 2E1) does not
-
br Drug Target Potential TM receptors
2020-07-31

Drug-Target Potential 7TM receptors and in particular class A receptors to which the 7TM receptors mentioned in this review belong, are highly druggable molecules. Approximately, 35% of all currently marketed drugs target class A 7TM receptors. There is no specific antiviral treatment for EBV. Cu
16556 records 838/1104 page Previous Next First page 上5页 836837838839840 下5页 Last page